Parker J Denz

11PUBLICATIONS
57CO-AUTHORS
Genetically modified animalsInnate immunityMedical infection agents (incl. prions)Molecular targetsComputational physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 29, 2026
IFITM3 deficiency drives SARS-CoV-2 adaptation while preserving variant-specific traits.

Parker J Denz, Samuel Speaks, Matthew I McFadden

|Sep 05, 2025
Cardioprotective effects of AMPK activation in H1N1 influenza virus infection.

Steve Leumi, Matthew McFadden, Naresh Kumar

|Feb 20, 2025
Accelerated Adaptation of SARS-CoV-2 Variants in Mice Lacking IFITM3 Preserves Distinct Tropism and Pathogenesis.

Parker J Denz, Jonathan L Papa, Matthew I McFadden

|Dec 11, 2024
Publisher Correction: Innate immune control of influenza virus interspecies adaptation via IFITM3.

Parker J Denz, Samuel Speaks, Adam D Kenney

|Oct 31, 2024
Innate immune control of influenza virus interspecies adaptation via IFITM3.

Parker J Denz, Samuel Speaks, Adam D Kenney

Pageof 2